ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,600.00
-4.50 (-0.28%)
17 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -4.50 -0.28% 1,600.00 1,598.00 1,599.00 1,613.00 1,589.00 1,613.00 3,788,149 16:35:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.35 65.81B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,604.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,820.00p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £65.81 billion. Gsk has a price to earnings ratio (PE ratio) of 13.35.

Gsk Share Discussion Threads

Showing 20376 to 20398 of 33275 messages
Chat Pages: Latest  827  826  825  824  823  822  821  820  819  818  817  816  Older
DateSubjectAuthorDiscuss
19/12/2019
14:59
But couldn't that take up to 2-3 years, yet?
tradermichael
19/12/2019
14:50
This may be due to Pfizer & GSK oncoming health division merger .
abdullla
19/12/2019
14:35
This has continued through the afternoon. Good underlying momentum in the share price now …. ;0)
tradermichael
19/12/2019
12:27
Share trades volume has been strong this morning … ;0)
tradermichael
19/12/2019
08:50
"Benlysta is the only biologic approved specifically for lupus and has moved slowly but surely toward blockbuster sales in the indication. In the first nine months of 2019, Benlysta posted $581 million in worldwide sales, a 32% jump from the same time period last year.
Adding an indication could boost the drug's sales even further, with about 60% of 328,000 severe U.S. lupus patients suffering from lupus nephritis each year," GSK said.

tradermichael
18/12/2019
16:03
"Glaxo's Benlysta successful in lupus nephritis study"


GlaxoSmithKline (GSK +0.3%) announces positive results from a Phase 3 clinical trial, BLISS-LN, evaluating Benlysta (belimumab) in patients with active lupus nephritis (LN), kidney inflammation caused by systemic lupus erythematosus (SLE), a condition occurring in up to 60% of SLE sufferers.

The study met the primary endpoint showing a statistically significantly greater proportion of patients treated with Benlysta + standard-of-care (SOC) therapy achieving renal response at week 104 compared to those receiving placebo + SOC (43% vs. 32%, p=0.0311).

crossing_the_rubicon
18/12/2019
09:18
Very pleasing move up and new high Undoubtedly benefiting a bit from pound weakness but more to come me thinks
panshanger1
18/12/2019
09:15
Ms Walmsley rubbing things up the right way
purplepelmets
18/12/2019
09:13
Aha, good newds, 1800 breached.
Where next after bumping up here before (1790's)?
Is it political certainty, is it cable...?
Probably trade the break-out would be a good move.

sogoesit
18/12/2019
09:08
Breakout!!! Yeeah baybee!
purplepelmets
17/12/2019
15:55
Profit taking on the big gains yesterday obviously ;-)
abdullla
17/12/2019
15:27
Large volumes traded today ….
tradermichael
17/12/2019
11:14
@Lippy,

hehe, indeed.
Suspect Santa bounce is coming though so we might be disappointed!

:)

crossing_the_rubicon
17/12/2019
11:11
bit of luck it will go down first...lol
lippy4
17/12/2019
10:55
GlaxoSmithKline said on Monday it had applied for U.S. approval for its experimental multiple myeloma drug that showed meaningful response in nearly a third of patients, setting up a battle against Johnson &
Johnson and Genmab's Darzalex.

Those geezers at Jefferies raised TP 2000p - BUY

crossing_the_rubicon
16/12/2019
14:13
Wasnt that Drug legislation championed by Trump???

"Trump has made a priority of trying to lower drug prices. But many of his most ardent supporters don’t know it"



He certainly was talking about it in 2016

"President Trump is backing off his 2016 campaign pledge to negotiate drug prices for Medicare with pharmaceutical companies"

The MSM though is painting it as Pelosi championing it..Which is partisan tosh.

The Democrats have appended MORE elements to this bill which is why it seemingly wont pass the Republican controlled Senate..

crossing_the_rubicon
16/12/2019
14:02
By a 230-192 margin, the U.S. House of Representatives has passed legislation, championed by Speaker Nancy Pelosi, aimed at corralling spiralling drug costs.

The bill's key provision would allow the feds to negotiate prices for expensive drugs that lack competition. A minimum of 50 medicines each year would be subject to talks.

A last-minute addition was a feasibility study to extend rebates for drug prices that increase faster than inflation to employer-sponsored coverage.

The bill has almost no chance to pass in the Republican-controlled Senate, however.

muscletrade
16/12/2019
13:10
oooh you are awful!!!!
lippy4
16/12/2019
13:03
could not hold any longer so sold..

i thought being a dollar earner with the rising pound this share would suffer or is it the amalgamation thats keeping it up..

lippy4
16/12/2019
12:34
I would sell half but keep the other half while sitting on the cash so earned,maybe :-))
abdullla
16/12/2019
12:25
If I don't sell, price would probably return to 1740p this afternoon.
If I did sell, it would probably reach 1800p! LOL ….. ;0)

tradermichael
16/12/2019
12:21
Its tempting, for me it would give a 19p profit (div) and a 19p gain (on the price) at 1775p, making £16K profit.
tradermichael
16/12/2019
12:00
TM,Having crystallised your divi do you think its time to sell ?
abdullla
Chat Pages: Latest  827  826  825  824  823  822  821  820  819  818  817  816  Older

Your Recent History

Delayed Upgrade Clock